Posted by Michael Wonder on 07 Apr 2021
TGA to review advertising of stem cell therapies to the Australian public
7 April 2021 - The Therapeutic Goods Administration, part of the Department of Health, is investigating the advertising of stem cell therapies to ensure that content in the public domain complies with the Australian rules for advertising therapeutic goods.
The term 'stem cell' therapies is often used to refer to autologous human cell and tissue (HCT) therapies. HCT products comprise, contain, or are derived from human cells and/or tissues. Autologous HCT products are those that are removed from, and applied to, the same person.
